Mireille Conserve, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 226 145th Ave, Spring Field, NY 11413 Phone: 917-297-5491 |
News Archive
Merck reported today that final results from two pivotal Phase III studies of boceprevir, its investigational oral hepatitis C protease inhibitor, demonstrated significantly higher sustained virologic response (SVR) rates in adult patients who previously failed treatment (treatment-failure; HCV RESPOND-2) and in adult patients who were new to treatment for chronic hepatitis C virus (HCV) genotype 1 compared to control, the primary objective of the studies.
For its 2010 second quarter, Ashland reported sales of $2,248 million, operating income of $151 million and net income of $22 million (27 cents per share). Net income was favorably affected by $2 million aftertax (2 cents per share) from discontinued operations. Cash flows provided by operating activities from continuing operations amounted to $183 million.
Wielding a joystick and wearing special glasses, pain researcher Alexandre DaSilva rotates and slices apart a large, colorful, 3-D brain floating in space before him.
A Norwegian study shows that asthma is three times more common in those who had a fAnchorather who smoked in adolescence than offspring who didn't.
genOway, the biotechnology company dedicated to the development of genetically modified animal models, today reports an agreement with the Griffith University (Brisbane, Australia) on a eight-months research partnership with its Eskitis Institute for Cell and Molecular Therapies focusing on autologous olfactory adult stem cells. This research program is coupled with a world wide exclusive license to genOway for the rodent transgenic business.
› Verified 2 days ago